Who are Naoxintong Capsule's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Xiaojin Pill.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/naoxintong-capsule.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Naoxintong Capsule — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Naoxintong Capsule (Naoxintong Capsule) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese Medicine (herbal formulation). Area: Cardiovascular.

marketed Traditional Chinese Medicine (herbal formulation) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Naoxintong Capsule (Naoxintong Capsule) — Chinese Academy of Medical Sciences, Fuwai Hospital. Naoxintong Capsule is a traditional Chinese medicine formulation that improves blood circulation and reduces blood stasis to treat cardiovascular and cerebrovascular conditions.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Naoxintong Capsule TARGET	Naoxintong Capsule	Chinese Academy of Medical Sciences, Fuwai Hospital	marketed	Traditional Chinese Medicine (herbal formulation)
Xiaojin Pill	Xiaojin Pill	Zhejiang Provincial People's Hospital	marketed	Traditional Chinese medicine (herbal formulation)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese Medicine (herbal formulation) class)

Chinese Academy of Medical Sciences, Fuwai Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Naoxintong Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/naoxintong-capsule. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing